Explore more publications!

California Commerce Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Commerce Daily.

Press releases published on October 18, 2025

Gilayo Unveils Concept for Robotic Assembly of Modular Steel Structures on Mars
JointCommerce Launches A21+ ‘Household Targeting’ Solution for Connected TV Video Advertising
Beydemüller Unveils Its First Collection: A New Era of Modern European Luxury Watches
KAZU 90.3 Welcomes SideBar: Optimism in Action Podcast
How Audfly’s Directional Sound Solution is Powering Interactive and Immersive Experiences in Museums
Crosby Brownlie Expands its Syracuse Location to Support Regional Growth
Bittam create No KYC, Up to 200× Leverage, Zero Slippage, Zero Funding Fees — 100% Deposit Bonus and Up to $3,000 New User Rewards!
BexBack Launches No KYC, 100x Leverage, and $50 Welcome Bonus for Easy Crypto Futures Trading!
Guaranteed Approval No Credit Check Loans – Honest Loans Most Trusted U.S. Lender 2025
Astra Bitcoin: Dr. Antoun Toubia Launches a Revolutionary Asset-Backed Ecosystem Built on Ethereum
Cearvol präsentiert auf der EUHA 2025 sein komplettes Hörgeräte-Sortiment und stellt sein Flaggschiff Wave mit fortschrittlicher KI- und Touchscreen-Technologie vor
Reconstruction and Opportunities: The CDFG Consumer White Paper 2024-2025 is Released
iFLYTEK AINOTE 2 kommt auf den Markt: Eine bahnbrechende Neuerung für die Produktivität im Beruf
Lancement de l’iFLYTEK AINOTE 2 : véritable révolution pour la productivité professionnelle
Celcuity Provides Update on Status of the PIK3CA Mutated Cohort of Phase 3 VIKTORIA-1 Trial and Releases Additional Data Analysis From Phase 1b Clinical Trial
Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
Blazpay’s Phase 2 of Crypto Presale Surges With Over $250,000 Raised as XRP and Bitcoin Consolidate
 Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
Piazza Garibaldi Introduces End-to-End Project Management for Ultra-Luxury Living and Yachting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions